search
verified Ph.D. Multi-Agent Verified auto_awesome Custom R&D Studio Enabled sync_alt Obsidian Vault Connected

Institutional-Grade Intelligence & Autonomous R&D Studio

Welcome, Dr. Neudoc. Your platform now features the Autonomous Custom R&D Studio. Enter custom hypotheses, assign our 5 Ph.D. specialist faculty leads (Dr. Vance, Dr. Lin, Dr. Sterling, Dr. Wright, Dr. Pepper), and generate publication-ready research reports with KaTeX formulas and high-contrast vector diagrams in real time.

Explore 3 Pre-Built Dossiers (18 Reports) folder_open
groups

Autonomous Research Faculty (5 Specialists Available for Co-Authoring)

Ready for Task Delegation
Dr. Pepper

Dr. Pepper

Executive Moderator & QC

Harmonizes interdisciplinary insights into structured institutional reports and conducts strict quality control.

Strategy Lead ● Ready
Dr. Vance

Dr. Vance

Pathophysiology Lead

Formulates secondary nucleation kinetics, synaptic vesicle opsonization, and vascular basement membrane degradation models.

Biophysics ● Ready
Dr. Lin

Dr. Lin

Clinical Diagnostics Lead

Designs 3-Tier Multi-Modal Algorithms, 15–25% grey-zone resolution cutoffs, and 3T MRI surveillance protocols.

Biomarkers ● Ready
Dr. Sterling

Dr. Sterling

Therapeutics Lead

Structures 4-step titration, TfR1 Brainshuttle platforms, oral TREM2 molecular glues, and multi-target combo trials.

Pharmacology ● Ready
Dr. Wright

Dr. Wright

Bioinformatics Lead

Compiles OpenTargets tractability, PDB structures, Ensembl genetics, and ClinicalTrials.gov evidence matrices.

Multi-Omics ● Ready
tune Clinical Staging Tool

3-Tier Staging Decision Simulator

Adjust biomarker parameters to model institutional staging and DMT eligibility recommendations in real-time.

science Model: AD-STG-v4.2
Plasma p-tau217 (pg/mL) 0.52
0.10 (Normal) 0.42–0.63 (Intermediate Grey-Zone) 1.50 (High)
Amyloid Burden (Centiloids) 22
0 CL (Negative) 25 CL (PET Positive Cutoff) 120 CL
Recommended Clinical Staging Live Engine
Tier 2 Reflex

Patient is in the 15–25% Intermediate Grey-Zone. Auto-escalate to mass spectrometry %p-tau217 ratio and qEEG functional connectivity.

Post-Test Prob
68.5%
DMT Window
Optimal
ARIA-E Risk
Moderate
lock_open Unrestricted Institutional Access Active

Institutional Strategic Research Dossiers

PUBLISHED: 2026-08-30 • FULL ACCESS ID: AD-DX-2026